LNTH FY 2015 Earnings — Lantheus Holdings, Inc. Revenue & Financial Results | Market Cap Arena

LNTHLantheus Holdings, Inc.

$5B

FY 2015 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$293M-2.7% YoY

Gross Profit

$136M46.2% margin

Operating Income

$43M14.5% margin

Net Income

-$15M-5.0% margin

EPS (Diluted)

$-0.60

Cash Flow

Operating Cash Flow

$22M

Free Cash Flow

$9M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$242M

Total Liabilities

$428M

Stockholders' Equity

-$185M

Cash & Equivalents

$29M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$293M	$302M	-2.7%
Gross Profit	$136M	$126M	+8.0%
Operating Income	$43M	$39M	+7.9%
Net Income	-$15M	-$4M	-314.1%